Results 211 to 220 of about 50,440 (256)

Current methods of testing for human papillomavirus

Best Practice & Research Clinical Obstetrics & Gynaecology, 2001
Human papillomavirus DNA testing is gaining wider acceptance, yet the majority of testing is still undertaken in the research setting using protocols that are unsuitable for clinical diagnostic laboratories. Large-scale clinical human papillomavirus DNA testing is likely to be introduced as an adjunct to cervical cytology, so the cytology laboratory is
P, Davies, J, Kornegay, T, Iftner
openaire   +2 more sources

Cervical screening: primary human papillomavirus testing

BJOG: An International Journal of Obstetrics & Gynaecology, 2012
Please cite this paper as: Cruickshank ME, Cubie HA. Cervical screening: primary human papillomavirus testing. BJOG 2012;119:650–652.
M E, Cruickshank, H A, Cubie
openaire   +2 more sources

Human Papillomavirus Testing for Triage in a Referral Population

Journal of Lower Genital Tract Disease, 2001
This study evaluated the Digene HPV Assay Hybrid Capture System(R) as a triage method.Results of an HPV assay were compared with a final tissue diagnosis of cervical intraepithelial neoplasia 2 (CIN2) or greater. These results were stratified based on Pap smear diagnosis and evaluated in 4 triage algorithms.Of the 4 algorithms evaluated, the highest ...
J, Gogola, T, Van Dinh, J A, Lucci, E, Smith, E V, Hannigan   +4 more
openaire   +2 more sources

Human papillomavirus testing in primary cervical screening

The Lancet, 1995
Several studies have examined the role of tests for human papillomavirus (HPV) in screening for cervical cancer but as yet the relevance is unclear. We looked at HPV testing for types 16, 18, 31, and 33 on material taken at the time of a cervical smear in 2009 eligible women having routine screening.
J, Cuzick, A, Szarewski, G, Terry, L, Ho, A, Hanby, P, Maddox, M, Anderson, G, Kocjan, S T, Steele, J, Guillebaud   +9 more
openaire   +2 more sources

Reflex human papillomavirus testing

Cancer, 2003
See referenced original article on pages 191–7,this issue.Address for reprints: Diane D. Davey, M.D., De-partment of Pathology and Laboratory Medicine,MS 117, University of Kentucky Medical Center,800 Rose St., Lexington, KY 40536-0298; Fax:(859) 323-2094; E-mail: Ddavey@uky.eduReceived April 3, 2003; accepted April 4, 2003.
openaire   +1 more source

Human papillomavirus testing and genotyping in cervical screening

Expert Review of Anticancer Therapy, 2011
Mass vaccination against human papillomavirus (HPV) genotypes 16 and 18 will, in the long term, reduce the incidence of cervical cancer, but screening will remain an important cancer control measure in both vaccinated and unvaccinated women. Since the 1960s, cytology screening has helped to reduce the incidence of cervical cancer, but has a low ...
Rebolj, Matejka, Lynge, Elsebeth, Bonde, Jesper   +2 more
openaire   +3 more sources

The value of human papillomavirus testing

The Obstetrician & Gynaecologist, 2003
Exfoliative cervical cytology has endured for 50 years and has been proven to reduce deaths from cervical cancer. Despite this, it lacks sensitivity and is also labour intensive. Human papillomavirus (HPV) has been shown to be a more sensitive test for detection of underlying cervical intraepithelial neoplasia (CIN). Because HPV is a necessary event in
openaire   +1 more source

The role of human papillomavirus testing in cervical screening

Journal of Clinical Virology, 2005
Organised, cytology-based cervical screening has led to a reduction in deaths associated with cervical cancer. Human papillomavirus (HPV) is necessary for the development of cervical cancer and associated pre-cursor cervical intraepithelial neoplasia and accumulated evidence suggests that incorporation of HPV testing could further refine screening ...
Kate S, Cuschieri, Heather A, Cubie
openaire   +2 more sources

Human Papillomavirus Testing in Cervical Cancer Screening

Obstetrics and Gynecology Clinics of North America, 2013
Human papillomavirus (HPV) testing is more reliable and sensitive but less specific than Papanicolaou (Pap) testing/cervical cytology for the detection of cervical precancer and cancer. HPV-negative women are at lower risk of cervical cancer than Pap-negative women.
Philip E, Castle, Miriam, Cremer
openaire   +2 more sources

Human papillomavirus testing in men.

The Journal of the American Osteopathic Association, 2011
Despite the morbidity associated with anogenital condylomas and the mortality associated with anal, penile, and cervical carcinoma as a direct consequence of human papillomavirus (HPV), the US Centers for Disease Control and Prevention currently does not recommend routine screening for HPV in immuno competent men. However, findings of emerging research
Kathleen F, McGinley, Wayne, Hey, David O, Sussman, Gordon A, Brown   +3 more
openaire   +1 more source